Table 4.
Year 01 |
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | ||
Soft Tissue Sarcoma | Stage | ||||||||||||
Distant/Metastatic | 33* | 22–48 | 42* | 29–61 | 60* | 43–83 | 69* | 50–95 | 73* | 53–100 | 90 | 74–100 | |
Local/Regional (ref) | 86 | 81–91 | 88 | 83–93 | 88 | 83–94 | 92 | 88–96 | 94 | 90–98 | 94 | 90–99 | |
Malignant Bone Tumor | Stage | ||||||||||||
Distant/Metastatic | 38* | 26–54 | 50* | 36–69 | 67* | 51–89 | 74* | 57–97 | 86 | 70–100 | 84 | 66–100 | |
Local/Regional (ref) | 79 | 73–86 | 79 | 73–86 | 89 | 83–95 | 89 | 83–95 | 92 | 87–98 | 95 | 90–100 |
p ≤ 0.05.
Year 0 starts at diagnosis.